Cozen O’Connor: The Amarin Win and the Next Big Question: What Will the FDA Do? [Drug and Device Law]

The Amarin Win and the Next Big Question: What Will the FDA Do? [Drug and Device Law]

John Sullivan, a member of Cozen O’Connor’s Commercial Litigation Department, discusses Amarin’s successful motion for a preliminary injunction in its First Amendment challenge to the FDA’s regulation of off-label marketing and discusses what this means for the FDA.

To read the article, click here.


Related Attorneys

John J. Sullivan

Member

jsullivan@cozen.com

(212) 453-3729


Related Practices